 | • レポートコード：GIR-105X06243 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、エンコラフェニブのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。エンコラフェニブの種類別市場規模（50mgカプセル、75mgカプセル）、用途別市場規模（病院、クリニック、薬局、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・エンコラフェニブの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Array BioPharma ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：50mgカプセル、75mgカプセル ・用途別分析2016年-2026年：病院、クリニック、薬局、その他 ・エンコラフェニブの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・エンコラフェニブのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・エンコラフェニブのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・エンコラフェニブの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・エンコラフェニブの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Encorafenib market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Encorafenib size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Encorafenib market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Encorafenib market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
50mg Capsules
75mg Capsules
Market segment by Application can be divided into
Hospital
Clinic
Pharmacy
Other
The key market players for global Encorafenib market are listed below:
Array BioPharma
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Encorafenib Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Encorafenib Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 50mg Capsules
1.2.3 75mg Capsules
1.3 Market Analysis by Application
1.3.1 Overview: Global Encorafenib Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Pharmacy
1.3.5 Other
1.4 Global Encorafenib Market Size & Forecast
1.4.1 Global Encorafenib Sales in Value (2016-2026))
1.4.2 Global Encorafenib Sales in Volume (2016-2026)
1.4.3 Global Encorafenib Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Encorafenib Production Capacity Analysis
1.5.1 Global Encorafenib Total Production Capacity (2016-2026)
1.5.2 Global Encorafenib Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Encorafenib Market Drivers
1.6.2 Encorafenib Market Restraints
1.6.3 Encorafenib Trends Analysis
2 Manufacturers Profiles
2.1 Array BioPharma
2.1.1 Array BioPharma Details
2.1.2 Array BioPharma Major Business
2.1.3 Array BioPharma Encorafenib Product and Services
2.1.4 Array BioPharma Encorafenib Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Encorafenib Sales by Manufacturer
3.1 Global Encorafenib Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Encorafenib Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Encorafenib
3.4 Market Concentration Rate
3.4.1 Top 3 Encorafenib Manufacturer Market Share
3.4.2 Top 6 Encorafenib Manufacturer Market Share
3.5 Global Encorafenib Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Encorafenib Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Encorafenib Market Size by Region
4.1.1 Global Encorafenib Sales in Volume by Region (2016-2026)
4.1.2 Global Encorafenib Revenue by Region (2016-2026)
4.2 North America Encorafenib Revenue (2016-2026)
4.3 Europe Encorafenib Revenue (2016-2026)
4.4 Asia-Pacific Encorafenib Revenue (2016-2026)
4.5 South America Encorafenib Revenue (2016-2026)
4.6 Middle East and Africa Encorafenib Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Encorafenib Sales in Volume by Type (2016-2026)
5.2 Global Encorafenib Revenue by Type (2016-2026)
5.3 Global Encorafenib Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Encorafenib Sales in Volume by Application (2016-2026)
6.2 Global Encorafenib Revenue by Application (2016-2026)
6.3 Global Encorafenib Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Encorafenib Sales by Type (2016-2026)
7.2 North America Encorafenib Sales by Application (2016-2026)
7.3 North America Encorafenib Market Size by Country
7.3.1 North America Encorafenib Sales in Volume by Country (2016-2026)
7.3.2 North America Encorafenib Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Encorafenib Sales by Type (2016-2026)
8.2 Europe Encorafenib Sales by Application (2016-2026)
8.3 Europe Encorafenib Market Size by Country
8.3.1 Europe Encorafenib Sales in Volume by Country (2016-2026)
8.3.2 Europe Encorafenib Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Encorafenib Sales by Type (2016-2026)
9.2 Asia-Pacific Encorafenib Sales by Application (2016-2026)
9.3 Asia-Pacific Encorafenib Market Size by Region
9.3.1 Asia-Pacific Encorafenib Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Encorafenib Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Encorafenib Sales by Type (2016-2026)
10.2 South America Encorafenib Sales by Application (2016-2026)
10.3 South America Encorafenib Market Size by Country
10.3.1 South America Encorafenib Sales in Volume by Country (2016-2026)
10.3.2 South America Encorafenib Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Encorafenib Sales by Type (2016-2026)
11.2 Middle East & Africa Encorafenib Sales by Application (2016-2026)
11.3 Middle East & Africa Encorafenib Market Size by Country
11.3.1 Middle East & Africa Encorafenib Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Encorafenib Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Encorafenib Typical Distributors
12.3 Encorafenib Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Encorafenib Revenue by Type, (USD Million), 2021-2026
Table 2. Global Encorafenib Revenue by Application, (USD Million), 2021-2026
Table 3. Array BioPharma Basic Information, Manufacturing Base and Competitors
Table 4. Array BioPharma Major Business
Table 5. Array BioPharma Encorafenib Product and Services
Table 6. Array BioPharma Encorafenib Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Global Encorafenib Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 8. Global Encorafenib Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 9. Market Position of Manufacturers in Encorafenib, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 10. Global Encorafenib Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 11. Head Office and Encorafenib Production Site of Key Manufacturer
Table 12. Global Encorafenib Sales by Region (2016-2021e) & (K Pcs)
Table 13. Global Encorafenib Sales by Region (2021-2026) & (K Pcs)
Table 14. Global Encorafenib Revenue by Region (2016-2021e) & (USD Million)
Table 15. Global Encorafenib Revenue by Region (2021-2026) & (USD Million)
Table 16. Global Encorafenib Sales by Type (2016-2021e) & (K Pcs)
Table 17. Global Encorafenib Sales by Type (2021-2026) & (K Pcs)
Table 18. Global Encorafenib Revenue by Type (2016-2021e) & (USD Million)
Table 19. Global Encorafenib Revenue by Type (2021-2026) & (USD Million)
Table 20. Global Encorafenib Price by Type (2016-2021e) & (USD/Pcs)
Table 21. Global Encorafenib Price by Type (2021-2026) & (USD/Pcs)
Table 22. Global Encorafenib Sales by Application (2016-2021e) & (K Pcs)
Table 23. Global Encorafenib Sales by Application (2021-2026) & (K Pcs)
Table 24. Global Encorafenib Revenue by Application (2016-2021e) & (USD Million)
Table 25. Global Encorafenib Revenue by Application (2021-2026) & (USD Million)
Table 26. Global Encorafenib Price by Application (2016-2021e) & (USD/Pcs)
Table 27. Global Encorafenib Price by Application (2021-2026) & (USD/Pcs)
Table 28. North America Encorafenib Sales by Country (2016-2021e) & (K Pcs)
Table 29. North America Encorafenib Sales by Country (2021-2026) & (K Pcs)
Table 30. North America Encorafenib Revenue by Country (2016-2021e) & (USD Million)
Table 31. North America Encorafenib Revenue by Country (2021-2026) & (USD Million)
Table 32. North America Encorafenib Sales by Type (2016-2021e) & (K Pcs)
Table 33. North America Encorafenib Sales by Type (2021-2026) & (K Pcs)
Table 34. North America Encorafenib Sales by Application (2016-2021e) & (K Pcs)
Table 35. North America Encorafenib Sales by Application (2021-2026) & (K Pcs)
Table 36. Europe Encorafenib Sales by Country (2016-2021e) & (K Pcs)
Table 37. Europe Encorafenib Sales by Country (2021-2026) & (K Pcs)
Table 38. Europe Encorafenib Revenue by Country (2016-2021e) & (USD Million)
Table 39. Europe Encorafenib Revenue by Country (2021-2026) & (USD Million)
Table 40. Europe Encorafenib Sales by Type (2016-2021e) & (K Pcs)
Table 41. Europe Encorafenib Sales by Type (2021-2026) & (K Pcs)
Table 42. Europe Encorafenib Sales by Application (2016-2021e) & (K Pcs)
Table 43. Europe Encorafenib Sales by Application (2021-2026) & (K Pcs)
Table 44. Asia-Pacific Encorafenib Sales by Region (2016-2021e) & (K Pcs)
Table 45. Asia-Pacific Encorafenib Sales by Region (2021-2026) & (K Pcs)
Table 46. Asia-Pacific Encorafenib Revenue by Region (2016-2021e) & (USD Million)
Table 47. Asia-Pacific Encorafenib Revenue by Region (2021-2026) & (USD Million)
Table 48. Asia-Pacific Encorafenib Sales by Type (2016-2021e) & (K Pcs)
Table 49. Asia-Pacific Encorafenib Sales by Type (2021-2026) & (K Pcs)
Table 50. Asia-Pacific Encorafenib Sales by Application (2016-2021e) & (K Pcs)
Table 51. Asia-Pacific Encorafenib Sales by Application (2021-2026) & (K Pcs)
Table 52. South America Encorafenib Sales by Country (2016-2021e) & (K Pcs)
Table 53. South America Encorafenib Sales by Country (2021-2026) & (K Pcs)
Table 54. South America Encorafenib Revenue by Country (2016-2021e) & (USD Million)
Table 55. South America Encorafenib Revenue by Country (2021-2026) & (USD Million)
Table 56. South America Encorafenib Sales by Type (2016-2021e) & (K Pcs)
Table 57. South America Encorafenib Sales by Type (2021-2026) & (K Pcs)
Table 58. South America Encorafenib Sales by Application (2016-2021e) & (K Pcs)
Table 59. South America Encorafenib Sales by Application (2021-2026) & (K Pcs)
Table 60. Middle East & Africa Encorafenib Sales by Country (2016-2021e) & (K Pcs)
Table 61. Middle East & Africa Encorafenib Sales by Country (2021-2026) & (K Pcs)
Table 62. Middle East & Africa Encorafenib Revenue by Country (2016-2021e) & (USD Million)
Table 63. Middle East & Africa Encorafenib Revenue by Country (2021-2026) & (USD Million)
Table 64. Middle East & Africa Encorafenib Sales by Type (2016-2021e) & (K Pcs)
Table 65. Middle East & Africa Encorafenib Sales by Type (2021-2026) & (K Pcs)
Table 66. Middle East & Africa Encorafenib Sales by Application (2016-2021e) & (K Pcs)
Table 67. Middle East & Africa Encorafenib Sales by Application (2021-2026) & (K Pcs)
Table 68. Direct Channel Pros & Cons
Table 69. Indirect Channel Pros & Cons
Table 70. Encorafenib Typical Distributors
Table 71. Encorafenib Typical Customers
List of Figures
Figure 1. Encorafenib Picture
Figure 2. Global Encorafenib Sales Market Share by Type in 2020
Figure 3. 50mg Capsules
Figure 4. 75mg Capsules
Figure 5. Global Encorafenib Sales Market Share by Application in 2020
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Pharmacy
Figure 9. Other
Figure 10. Global Encorafenib Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 11. Global Encorafenib Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. United States Encorafenib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Canada Encorafenib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Mexico Encorafenib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Germany Encorafenib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. France Encorafenib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. United Kingdom Encorafenib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Russia Encorafenib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Italy Encorafenib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. China Encorafenib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Japan Encorafenib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Korea Encorafenib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. India Encorafenib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Southeast Asia Encorafenib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Australia Encorafenib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Brazil Encorafenib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Egypt Encorafenib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Saudi Arabia Encorafenib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. South Africa Encorafenib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Turkey Encorafenib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Global Encorafenib Sales (2016-2026) & (K Pcs)
Figure 32. Global Encorafenib Production Capacity (2016-2026) & (K Pcs)
Figure 33. Global Encorafenib Production Capacity by Geographic Region: 2020 VS 2021
Figure 34. Encorafenib Market Drivers
Figure 35. Encorafenib Market Restraints
Figure 36. Encorafenib Market Trends
Figure 37. Global Encorafenib Sales Market Share by Manufacturer in 2020
Figure 38. Global Encorafenib Revenue Market Share by Manufacturer in 2020
Figure 39. Encorafenib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 40. Top 3 Encorafenib Manufacturer (Revenue) Market Share in 2020
Figure 41. Top 6 Encorafenib Manufacturer (Revenue) Market Share in 2020
Figure 42. Global Encorafenib Sales Market Share by Region (2016-2026)
Figure 43. Global Encorafenib Revenue Market Share by Region (2016-2026)
Figure 44. North America Encorafenib Revenue (2016-2026) & (USD Million)
Figure 45. Europe Encorafenib Revenue (2016-2026) & (USD Million)
Figure 46. Asia-Pacific Encorafenib Revenue (2016-2026) & (USD Million)
Figure 47. South America Encorafenib Revenue (2016-2026) & (USD Million)
Figure 48. Middle East & Africa Encorafenib Revenue (2016-2026) & (USD Million)
Figure 49. Global Encorafenib Sales Market Share by Type (2016-2026)
Figure 50. Global Encorafenib Revenue Market Share by Type (2016-2026)
Figure 51. Global Encorafenib Price by Type (2016-2026) & (USD/Pcs)
Figure 52. Global Encorafenib Sales Market Share by Application (2016-2026)
Figure 53. Global Encorafenib Revenue Market Share by Application (2016-2026)
Figure 54. Global Encorafenib Price by Application (2016-2026) & (USD/Pcs)
Figure 55. North America Encorafenib Sales Market Share by Country (2016-2026)
Figure 56. North America Encorafenib Revenue Market Share by Country (2016-2026)
Figure 57. North America Encorafenib Sales Market Share by Type (2016-2026)
Figure 58. North America Encorafenib Sales Market Share by Application (2016-2026)
Figure 59. Europe Encorafenib Sales Market Share by Country (2016-2026)
Figure 60. Europe Encorafenib Revenue Market Share by Country (2016-2026)
Figure 61. Europe Encorafenib Sales Market Share by Type (2016-2026)
Figure 62. Europe Encorafenib Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Encorafenib Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Encorafenib Revenue Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Encorafenib Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Encorafenib Sales Market Share by Application (2016-2026)
Figure 67. South America Encorafenib Sales Market Share by Country (2016-2026)
Figure 68. South America Encorafenib Revenue Market Share by Country (2016-2026)
Figure 69. South America Encorafenib Sales Market Share by Type (2016-2026)
Figure 70. South America Encorafenib Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Encorafenib Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Encorafenib Revenue Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Encorafenib Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Encorafenib Sales Market Share by Application (2016-2026)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
世界のデンプン空カプセル市場 2021：企業別、地域別、種類・用途別 The Starch Empty Capsules market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…- 世界の茶カプセル市場 2021：企業別、地域別、種類・用途別 The Tea Capsules market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recen…
- 世界のタラゾパリブ市場 2021：企業別、地域別、種類・用途別 The Talazoparib market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent…
- 世界のインダカテロール市場 2021：企業別、地域別、種類・用途別 The Indacaterol market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent…
- 世界の薬局用自動包装・ラベリングシステム市場 2021：企業別、地域別、種類・用途別 The Pharmacy Automated Packaging and Labeling Systems market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain o…